A Study of QLM2011 in Subjects With Advanced Solid Tumors

Clinical trial NCT06925659 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06925659
Sponsor: Qilu Pharmaceutical (Hainan) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-05-01
Primary completion: 2026-06-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.